Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations

BACKGROUND: Recently, the Expanded Prostate Cancer Index Composite 26-item version (EPIC-26) was recommended for the assessment of adverse effects after the treatment of prostate cancer without clear reasons. This decision encouraged us to review the questionnaire development from the UCLA Prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Axcrona, Karol, Nilsson, Rasmus, Brennhovd, Bjørn, Sørebø, Øystein, Fosså, Sophie D., Dahl, Alv A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712157/
https://www.ncbi.nlm.nih.gov/pubmed/29197360
http://dx.doi.org/10.1186/s12894-017-0302-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5712157/
https://www.ncbi.nlm.nih.gov/pubmed/29197360
http://dx.doi.org/10.1186/s12894-017-0302-7

Ejemplares similares